A detailed history of Bernzott Capital Advisors transactions in Johnson & Johnson stock. As of the latest transaction made, Bernzott Capital Advisors holds 39,381 shares of JNJ stock, worth $6.5 Million. This represents 2.83% of its overall portfolio holdings.

Number of Shares
39,381
Previous 44,148 10.8%
Holding current value
$6.5 Million
Previous $6.98 Million 17.59%
% of portfolio
2.83%
Previous 2.94%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 26, 2024

SELL
$144.38 - $157.78 $688,259 - $752,137
-4,767 Reduced 10.8%
39,381 $5.76 Million
Q1 2024

May 01, 2024

BUY
$155.22 - $162.74 $377,805 - $396,109
2,434 Added 5.83%
44,148 $6.98 Million
Q4 2023

Feb 12, 2024

SELL
$145.6 - $158.88 $81,681 - $89,131
-561 Reduced 1.33%
41,714 $6.54 Million
Q3 2023

Oct 23, 2023

SELL
$155.75 - $174.48 $970,634 - $1.09 Million
-6,232 Reduced 12.85%
42,275 $6.58 Million
Q2 2023

Jul 27, 2023

SELL
$154.35 - $166.11 $210,687 - $226,740
-1,365 Reduced 2.74%
48,507 $8.03 Million
Q1 2023

Apr 27, 2023

SELL
$151.05 - $180.26 $1.92 Million - $2.29 Million
-12,679 Reduced 20.27%
49,872 $7.73 Million
Q4 2022

Jan 18, 2023

BUY
$160.2 - $179.79 $229,566 - $257,639
1,433 Added 2.34%
62,551 $0
Q3 2022

Dec 22, 2022

BUY
$161.33 - $179.52 $11,454 - $12,745
71 Added 0.12%
61,118 $9.98 Million
Q3 2022

Oct 18, 2022

SELL
$161.33 - $179.52 $85,827 - $95,504
-532 Reduced 0.86%
61,047 $9.97 Million
Q2 2022

Jul 25, 2022

SELL
$168.19 - $186.01 $482,705 - $533,848
-2,870 Reduced 4.45%
61,579 $10.9 Million
Q1 2022

Apr 20, 2022

SELL
$158.14 - $179.59 $160,828 - $182,643
-1,017 Reduced 1.55%
64,449 $11.4 Million
Q4 2021

Feb 03, 2022

SELL
$155.93 - $173.01 $691,081 - $766,780
-4,432 Reduced 6.34%
65,466 $11.2 Million
Q3 2021

Oct 19, 2021

BUY
$161.5 - $179.47 $255,977 - $284,459
1,585 Added 2.32%
69,898 $11.3 Million
Q2 2021

Aug 10, 2021

BUY
$159.48 - $171.07 $208,440 - $223,588
1,307 Added 1.95%
68,313 $11.3 Million
Q1 2021

May 13, 2021

SELL
$153.07 - $170.48 $958,065 - $1.07 Million
-6,259 Reduced 8.54%
67,006 $11 Million
Q4 2020

Feb 12, 2021

SELL
$137.11 - $157.38 $894,231 - $1.03 Million
-6,522 Reduced 8.17%
73,265 $11.5 Million
Q3 2020

Nov 12, 2020

BUY
$140.38 - $153.83 $875,690 - $959,591
6,238 Added 8.48%
79,787 $11.9 Million
Q2 2020

Aug 19, 2020

SELL
$128.81 - $155.51 $259,938 - $313,819
-2,018 Reduced 2.67%
73,549 $10.3 Million
Q1 2020

May 14, 2020

SELL
$111.14 - $153.99 $862,779 - $1.2 Million
-7,763 Reduced 9.32%
75,567 $9.91 Million
Q4 2019

Feb 12, 2020

BUY
$127.5 - $146.44 $790,245 - $907,635
6,198 Added 8.04%
83,330 $12.2 Million
Q3 2019

Nov 12, 2019

BUY
$126.95 - $142.14 $126,950 - $142,140
1,000 Added 1.31%
77,132 $9.98 Million
Q2 2019

Aug 12, 2019

SELL
$131.15 - $144.24 $206,692 - $227,322
-1,576 Reduced 2.03%
76,132 $10.6 Million
Q1 2019

May 16, 2019

BUY
$125.72 - $139.79 $305,499 - $339,689
2,430 Added 3.23%
77,708 $10.9 Million
Q4 2018

Feb 11, 2019

SELL
$122.84 - $147.84 $859 - $1,034
-7 Reduced 0.01%
75,278 $9.72 Million
Q3 2018

Nov 14, 2018

BUY
$121.58 - $142.88 $24,316 - $28,576
200 Added 0.27%
75,285 $10.4 Million
Q2 2018

Aug 10, 2018

BUY
$119.4 - $131.76 $655,506 - $723,362
5,490 Added 7.89%
75,085 $9.11 Million
Q1 2018

May 10, 2018

SELL
$125.1 - $148.14 $175,765 - $208,136
-1,405 Reduced 1.98%
69,595 $8.92 Million
Q4 2017

Feb 13, 2018

BUY
$131.22 - $143.62 $1.15 Million - $1.26 Million
8,775 Added 14.1%
71,000 $9.92 Million
Q3 2017

Nov 13, 2017

BUY
$129.47 - $135.38 $8.06 Million - $8.42 Million
62,225
62,225 $8.09 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $431B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Bernzott Capital Advisors Portfolio

Follow Bernzott Capital Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bernzott Capital Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Bernzott Capital Advisors with notifications on news.